CurrentRheuma coverage · page 39 of 48

Rheumatology (Oxford)

Briefs 1,521–1,560 of 1,905 CurrentRheuma has covered from this journal, newest publication first

Latest from Rheumatology (Oxford)

All coverage, newest first

Rheumatology (Oxford)15 May 2023
Tumour-associated antigens in systemic lupus erythematosus: association with clinical manifestations and serological indicators
Cohort studyLupus & APS
Rheumatology (Oxford)15 May 2023
Combining multimodal magnetic resonance brain imaging and machine learning to unravel neurocognitive function in non-neuropsychiatric systemic lupus erythematosus
Cross-sectional studyLupus & APS
Rheumatology (Oxford)15 May 2023
Adherence to dietary guidelines, and the risk of developing rheumatoid arthritis: results from a nested case-control study
Case-control studyRA
Rheumatology (Oxford)15 May 2023
Fibroblast growth factor receptor 1 as a potential marker of terminal effector peripheral T helper cells in rheumatoid arthritis patients
Mechanistic studyRA
Rheumatology (Oxford)12 May 2023
Health-related quality of life in patients with ANCA vasculitides compared to rheumatoid arthritis: a cross-sectional comparative study
Cross-sectional studyVasculitis & PMR
Rheumatology (Oxford)11 May 2023
The association between sonographic enthesitis with sonographic synovitis and tenosynovitis in psoriatic arthritis patients
Cross-sectional studySpondyloarthritis & PsA
Rheumatology (Oxford)9 May 2023
Treatment with mycophenolate mofetil is associated with improved nailfold vasculature in systemic sclerosis
Cohort studySystemic sclerosis
Rheumatology (Oxford)8 May 2023
The differential crosstalk of the skin–gut microbiome axis as a new emerging actor in systemic sclerosis
Cross-sectional studySystemic sclerosis
Rheumatology (Oxford)5 May 2023
Association of anti-TPM4 autoantibodies with vasculopathic cutaneous manifestations in juvenile dermatomyositis
Cross-sectional studyPediatric
Rheumatology (Oxford)5 May 2023
Validation of a patient-reported outcome measure for giant cell arteritis
Cross-sectional studyVasculitis & PMR
Rheumatology (Oxford)4 May 2023
Ten-year safety and clinical benefit from open-label etanercept treatment in children and young adults with juvenile idiopathic arthritis
Research articlePediatric
Rheumatology (Oxford)3 May 2023
Differences in transcriptional changes in psoriasis and psoriatic arthritis skin with immunoglobulin gene enrichment in psoriatic arthritis
Mechanistic studySpondyloarthritis & PsA
Rheumatology (Oxford)3 May 2023
Does the halo count on temporal and axillary ultrasound predict time to relapse in giant cell arteritis?
Cohort studyVasculitis & PMR
Rheumatology (Oxford)2 May 2023
Ultraprocessed food consumption, genetic predisposition, and the risk of gout: the UK Biobank study
Cohort studyGout & crystals
Rheumatology (Oxford)2 May 2023
Association of the AAV-PRO questionnaire with established outcome measures in AAV
Cohort studyVasculitis & PMR
Rheumatology (Oxford)2 May 2023
Prevalence and characteristics of subclinical giant cell arteritis in polymyalgia rheumatica
Cross-sectional studyVasculitis & PMR
Rheumatology (Oxford)2 May 2023
Safety of the JAK and TNF inhibitors in rheumatoid arthritis: real world data from the Hong Kong Biologics Registry
Cohort studyRA
Rheumatology (Oxford)28 Apr 2023
Diagnosing and managing dysphagia in inclusion body myositis: a systematic review
Meta-analysisMyositis
Rheumatology (Oxford)27 Apr 2023
The bidirectional association between chronic musculoskeletal pain and sleep-related problems: a systematic review and meta-analysis
Meta-analysisFibromyalgia & pain
Rheumatology (Oxford)25 Apr 2023
Enthesitis in patients with psoriatic arthritis treated with secukinumab or adalimumab: a post hoc analysis of the EXCEED study
Secondary analysisSpondyloarthritis & PsA
Rheumatology (Oxford)24 Apr 2023
The diagnostic value of sST2 for myocardial fibrosis in idiopathic inflammatory myopathies in subclinical stage of cardiac involvement
Diagnostic or prognostic studyMyositis
Rheumatology (Oxford)24 Apr 2023
Magnetic resonance imaging characteristics in patients with psoriatic arthritis and axial manifestations from the MAXIMISE cohort
Secondary analysisSpondyloarthritis & PsA
Rheumatology (Oxford)24 Apr 2023
Which extra-renal flare is ‘difficult to treat’ in systemic lupus erythematosus? A one-year longitudinal study comparing traditional and machine learning approaches
Cohort studyLupus & APS
Rheumatology (Oxford)22 Apr 2023
Kv1.3 blockade by ShK186 modulates CD4+ effector memory T-cell activity of patients with granulomatosis with polyangiitis
Mechanistic studyVasculitis & PMR
Rheumatology (Oxford)22 Apr 2023
Paranasal sinus occupancy assessed from magnetic resonance images—associations with clinical indicators in patients with systemic lupus erythematosus
Cross-sectional studyLupus & APS
Rheumatology (Oxford)22 Apr 2023
The impact of traditional cardiovascular risk factor control on 7-year follow-up atherosclerosis progression in systemic lupus erythematosus
Cohort studyLupus & APS
Rheumatology (Oxford)21 Apr 2023
Flares in IIMs and the timeline following COVID-19 vaccination: a combined analysis of the COVAD-1 and -2 surveys
Cross-sectional studyMyositis
Rheumatology (Oxford)21 Apr 2023
Reactive arthritis after COVID-19 vaccination: 17 cases
Cohort studySpondyloarthritis & PsA
Rheumatology (Oxford)20 Apr 2023
Semi-quantitative thigh magnetic resonance imaging scores in assessing disease activity and determining long-term clinical outcome in idiopathic inflammatory myopathies: a causal mediation analysis
Cohort studyMyositis
Rheumatology (Oxford)20 Apr 2023
CONQUER Scleroderma: association of gastrointestinal tract symptoms in early disease with resource utilization
Cohort studySystemic sclerosis
Rheumatology (Oxford)20 Apr 2023
Sirolimus for the treatment of patients with refractory connective tissue disease-related thrombocytopenia: a pilot study
Cohort studyLupus & APS
Rheumatology (Oxford)20 Apr 2023
The role of antidrug antibodies in ustekinumab therapy and the impact of methotrexate
Secondary analysisSpondyloarthritis & PsA
Rheumatology (Oxford)19 Apr 2023
Prognostic value of automated assessment of interstitial lung disease on CT in systemic sclerosis
Diagnostic or prognostic studySystemic sclerosis
Rheumatology (Oxford)13 Apr 2023
In-depth proteomic analysis of juvenile dermatomyositis serum reveals protein expression associated with muscle-specific autoantibodies
Mechanistic studyPediatric
Rheumatology (Oxford)13 Apr 2023
Cancer risk in patients with rheumatoid arthritis treated with janus kinase inhibitors: a nationwide Danish register-based cohort study
Cohort studyRA
Rheumatology (Oxford)12 Apr 2023
Intestinal uric acid excretion contributes to serum uric acid decrease during acute gout attack
Mechanistic studyGout & crystals
Rheumatology (Oxford)11 Apr 2023
Does remission in systemic lupus erythematosus according to the 2021 DORIS definition match the treating rheumatologist’s judgement?
Cross-sectional studyLupus & APS
Rheumatology (Oxford)6 Apr 2023
Early-onset gout and rare deficient variants of the lactate dehydrogenase D gene
Research articleGout & crystals
Rheumatology (Oxford)6 Apr 2023
Treatment decisions in axial spondyloarthritis daily clinical practice are more than treat-to-target
Cross-sectional studySpondyloarthritis & PsA
Rheumatology (Oxford)5 Apr 2023
Cost-effectiveness of cognitive behavioural and personalized exercise interventions for reducing fatigue in inflammatory rheumatic diseases
Randomized controlled trialAcross diseases

All 1,905 Briefs in ExploreShowing Briefs 1,521–1,560 of 1,905, newest first